U.S. Stock News

If you are wondering whether Warby Parker's current share price lines up with its underlying value, this breakdown is designed to help you frame that question clearly. The stock recently closed at US$21.30, with returns of 28.9% over 1 year and 93.3% over 3 years, while showing recent pullbacks of 0.5% over 7 days, 15.7% over 30 days, and 5.8% year to date. These recent moves sit against a backdrop of ongoing interest in Warby Parker's direct to consumer eyewear model and its expansion...

If you are wondering whether Chord Energy at around US$134.93 is still offering value, the key question is how its market price compares with its fundamentals. The stock has had a mixed short term path, with a 1.5% decline over the last 7 days, a 9.5% gain over the last 30 days, and returns of 42.5% year to date and 49.5% over the past year. Recent coverage has focused on Chord Energy's position within the wider oil and gas sector and how investor sentiment around the company aligns with...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Celebrations may be in order for APA Corporation ( NASDAQ:APA ) shareholders, with the analysts delivering a...

We wouldn't blame Willis Lease Finance Corporation ( NASDAQ:WLFC ) shareholders if they were a little worried about the...

Even though Lexeo Therapeutics, Inc. ( NASDAQ:LXEO ) stock gained 14% last week, insiders who sold US$381k worth of...

Some Semtech Corporation ( NASDAQ:SMTC ) shareholders may be a little concerned to see that the Executive VP & Chief...

Spire Global (SPIR) has drawn fresh attention after rolling out an expanded agriculture intelligence platform that fuses 40 years of soil moisture data with daily satellite readings, extended forecasts, and AI driven seasonal guidance. See our latest analysis for Spire Global. The latest agriculture platform launch comes after a busy few weeks that included a ten satellite mission supporting projects in quantum sensing, optical inter satellite links, Earth observation, and IoT connectivity,...

Wondering whether Genco Shipping & Trading's current share price reflects its true worth, or if the market is missing something? The stock last closed at US$24.32, with returns of 4.7% over 7 days, 12.7% over 30 days, 31.9% year to date and 104.9% over the past year. This raises questions about how much of the story is already in the price. Recent coverage has focused on Genco Shipping & Trading's position within the shipping sector and how investors are reacting to changing sentiment around...

Wondering whether OSI Systems at around US$288 a share still represents value, or if most of the opportunity is already priced in? This article walks through the key signals to help you frame that question for yourself. The stock has recent returns of 9.4% over 7 days, 2.2% over 30 days, 12.9% year to date, 50.9% over 1 year, 180.6% over 3 years and 198.6% over 5 years, which naturally raises questions about where valuation stands today. Recent coverage has kept attention on OSI Systems,...

Brookfield Wealth Solutions, listed as NYSE:BNT, is in focus as its parent company prepares a $1b transfer of Brookfield Business Corporation shares. The company has also completed a major acquisition of Just Group, adding substantially to its global insurance assets under management. These actions represent a material shift in Brookfield Wealth Solutions' structure and exposure, going beyond routine financial updates. For you as an investor, these moves matter because Brookfield Wealth...

DXC Technology (NYSE:DXC) has entered a multi year partnership with ServiceNow to roll out ServiceNow’s new agentic AI tools across DXC’s core business operations. DXC will act as "Customer Zero" for ServiceNow’s Core Business Suite, using the platform internally before it is broadly offered to clients. The collaboration is aimed at deploying scalable AI led automation and more streamlined enterprise functions for DXC and its customers. For investors watching NYSE:DXC, this partnership...

If you are wondering whether Ultragenyx Pharmaceutical at US$23.15 is a bargain or a value trap, the key is understanding what the current price actually implies about the business. The stock has returned 8.1% over the last week and 2.4% over the last month, but is still showing a 1.9% decline year to date and a 31.7% decline over the last year, with even deeper 3 year and 5 year returns of 38.3% and 78.6% respectively. These moves sit against a backdrop of ongoing interest in rare disease...

Why PriceSmart's Latest Earnings Are Back in Focus PriceSmart (PSMT) is back on investors’ radar after reporting fiscal second quarter results that showed higher revenue and net income year over year, alongside plans for new clubs and supply chain upgrades across its markets. See our latest analysis for PriceSmart. The earnings release and club expansion plans appear to have coincided with stronger trading interest, with a 27.1% year to date share price return and an 84.5% one year total...

Investors may be wondering whether Affiliated Managers Group at around US$286.48 is still offering value, or if most of the easy gains are already on the table. The stock has moved 4.7% over the last 7 days and 1.8% over the last 30 days, with a 79.3% return over 1 year, 106.1% over 3 years and 83.0% over 5 years, even though the year to date return sits at a slight 0.8% decline. Recent coverage has focused on how asset managers are positioning for changing investor preferences and capital...

Mid-America Apartment Communities (MAA) is back in focus as analysts update their views, the REIT prepares to report upcoming earnings, and insiders execute planned share sales alongside a recently confirmed quarterly dividend. See our latest analysis for Mid-America Apartment Communities. The recent 1-day share price return of 1.44% and 7-day gain of 2.89% to US$126.09 sit against a weaker backdrop, with a 30-day share price return of 4.58% and a 1-year total shareholder return of 16.66%...

Kura Sushi USA (KRUS) opened Q2 2026 with revenue of US$80.0 million, a basic EPS loss of US$0.14, and net income loss of US$1.7 million, setting the tone for another quarter where top line growth is front and center while profitability remains under pressure. The company has reported quarterly revenue increasing from US$64.9 million in Q2 2025 to US$80.0 million in Q2 2026, while basic EPS moved from a loss of US$0.31 to a loss of US$0.14 over the same period, alongside a trailing twelve...

AI runs on real world hardware, and right now that physical backbone is where a lot of the attention is going. While energy prices, interest rate expectations, and geopolitical tensions are keeping many sectors on edge, the companies building data centers, power connections, and cooling systems are dealing in tangible demand. The AI Infrastructure Stocks screener focuses on those providers that are turning sales into cash flow, instead of just selling a story. In this article, you will see 3...

Markets are being pulled in different directions by energy prices, interest rate expectations, and shifting inflation trends, and that can make it harder to know where to focus. One clear anchor is leadership that is deeply invested in its own business. Founder led companies, where leaders typically hold meaningful stakes and think in decades rather than quarters, can offer a different quality of commitment. This article looks at our Top Founder Led Companies screener and highlights three...

Nurix Therapeutics (NRIX) opened 2026 with Q1 revenue of US$6.3 million and a basic EPS loss of US$0.79, while trailing twelve month figures show revenue of US$71.8 million against a basic EPS loss of US$3.17, framing a business that is still firmly in investment mode. Over the past year, the company has seen quarterly revenue range from US$6.3 million to US$44.1 million and basic EPS move between a loss of US$0.52 and a loss of US$1.03, giving investors a clear view of how top line progress...

Kiniksa Pharmaceuticals International (NasdaqGS:KNSA) has launched Heart’s Home, a Direct-to-Consumer campaign focused on ARCALYST for recurrent pericarditis. The campaign aims to expand awareness and empower patients about the only FDA approved therapy for recurrent pericarditis. Heart’s Home represents a new commercial effort to reach patients directly outside the traditional physician focused model. Kiniksa Pharmaceuticals International, listed on NasdaqGS:KNSA, develops and...

BOK Financial (NasdaqGS:BOKF) has promoted Scott Andrews to lead its Specialized Industries Banking group. The appointment follows the planned retirement of Executive Vice President Brad Vincent. The transition affects key lines of business including commercial real estate, energy, and healthcare banking. BOK Financial’s Specialized Industries Banking unit sits at the core of its commercial franchise, with exposure to sectors that tend to be closely watched by lenders and regulators. Areas...

Aehr Test Systems (AEHR) has released its Q3 2026 numbers, reporting revenue of US$10.3 million and a basic EPS loss of US$0.10, alongside net income excluding extra items of a US$3.2 million loss. The company has seen quarterly revenue move between US$13.5 million and US$18.3 million since Q2 2025, while basic EPS has ranged from a profit of US$0.78 per share on a trailing twelve month basis in 2025 to a loss of US$0.38 per share over the most recent twelve month window. This keeps the focus...

If you are wondering whether PagSeguro Digital's current share price truly reflects its underlying worth, this article walks through the key signals you can use to judge that. The stock recently closed at US$10.76, with returns of 2.2% over the last 7 days, 7.8% over 30 days, 11.3% year to date, 35.4% over 1 year, 31.3% over 3 years and a 75.3% decline over 5 years. Recent coverage has focused on PagSeguro Digital's position within diversified financials and how changing views on digital...